CardioSafe+: A Platform for Telerehabilitation and Monitoring of Patients With Heart Problems
NCT ID: NCT05865158
Last Updated: 2023-11-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2022-09-20
2024-06-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of the ECG Watch in Palpitation Assessment: Feasibility Study
NCT07121816
Safety Acceptability and Benefits of Tracking Cardiac Pacemakers by Carelink Express
NCT03140150
Heart Smart: A Virtual Self-Management Program for Homebound People With Heart Failure
NCT05057364
SmartCardia Wireless Recorder as a Telemetry System
NCT04609436
Development and Validation of a Telemonitoring System for High-risk Cardiovascular Patients
NCT05485532
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Key components to be evaluated include:
Maximal Respiratory Pressures: This involves measuring the maximum force generated during inspiration and expiration, which can indicate respiratory muscle strength and function.
Exertion Capacity: The assessment aims to gauge the participants' ability to engage in physical activities, potentially reflecting improvements in overall cardiovascular fitness and endurance.
Subjective Sensation of Exertion: This component involves understanding how the participants perceive and rate their own exertion during exercises, contributing to insights about their subjective experience and effort perception.
The intervention's objective is to collect data on these parameters before and after the six-week exercise program utilizing the CardioSafe+ digital platform. This data will help determine the effectiveness of the platform in aiding individuals recovering from cardiovascular pathologies and could provide valuable insights for further implementing tele-rehabilitation in managing such health complications.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Institionalized group
Group of institutionalized people with chronic cardiovascular diseases.
Home-based exercises
Home-based exercises proposed through the CardioSafe+ platform, guided by therapists specialized in cardiovascular disorders, who will try to adapt the sessions to each participant.
Community-dwelling group
Group of community-dwelling people with chronic cardiovascular diseases.
Home-based exercises
Home-based exercises proposed through the CardioSafe+ platform, guided by therapists specialized in cardiovascular disorders, who will try to adapt the sessions to each participant.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home-based exercises
Home-based exercises proposed through the CardioSafe+ platform, guided by therapists specialized in cardiovascular disorders, who will try to adapt the sessions to each participant.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* To be in a stable medical situation.
* To have access to technological resources and knowledge for their use.
Exclusion Criteria
* People who present insufficient capacity to understand and obey the instructions offered by the researchers, both in the evaluation and in the intervention.
* People who have a cardiac pathology with obvious fluctuations in the course of the disease.
* The presence of an acute episode of the disease during the intervention period.
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Salamanca
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Beatriz-María Bermejo-Gil
Assistant professor doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beatriz María Bermejo Gil
Role: PRINCIPAL_INVESTIGATOR
University of Salamanca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beatriz María Bermejo Gil
Salamanca, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CardioSafe+
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.